Hongbo Guo

The National Key Clinical Specialty, Guangdong Provincial Key Laboratory On Brain Function Repair And Regeneration
Guangzhou, 510260, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

TAGLN2 promotes mesenchymal circulating tumor cell-associated metastasis through the CSNK1E-YAP Axis with concomitant EMT induction and metabolic remodeling in hepatocellular carcinoma.

TAGLN2 promotes mesenchymal circulating tumor cell-associated metastasis through the CSNK1E-YAP Axis with concomitant EMT induction and metabolic remodeling in hepatocellular carcinoma.

Journal: Cellular signalling
Published: July 04, 2026

Pharmacological induction of mitochondria-lysosome hyper-tethering elicits synthetic lethality in glioblastoma.

Pharmacological induction of mitochondria-lysosome hyper-tethering elicits synthetic lethality in glioblastoma.

Journal: Cancer letters
Published: January 29, 2026

Lock-equipped six-helix DNA bundle-mediated siSTING delivery ameliorates Alzheimer's disease via cGAS-STING inhibition.

Lock-equipped six-helix DNA bundle-mediated siSTING delivery ameliorates Alzheimer's disease via cGAS-STING inhibition.

Journal: Journal of nanobiotechnology
Published: December 02, 2025

Long-Term Outcomes of Reduced-Dose Radiation Therapy in Patients with Epstein-Barr Virus DNA-Selected Stage III Nasopharyngeal Carcinoma: A 5-Year Follow-Up Secondary Analysis of a Phase II Trial.

Long-Term Outcomes of Reduced-Dose Radiation Therapy in Patients with Epstein-Barr Virus DNA-Selected Stage III Nasopharyngeal Carcinoma: A 5-Year Follow-Up Secondary Analysis of a Phase II Trial.

Journal: International journal of radiation oncology, biology, physics
Published: December 01, 2025

Efficacy of immunotherapy rechallenge in locoregionally advanced nasopharyngeal carcinoma after progression: A real-world analysis.

Efficacy of immunotherapy rechallenge in locoregionally advanced nasopharyngeal carcinoma after progression: A real-world analysis.

Journal: Med (New York, N.Y.)
Published: September 10, 2025

Immunological and pathological characteristics of brain parenchymal and leptomeningeal metastases from non-small cell lung cancer.

Immunological and pathological characteristics of brain parenchymal and leptomeningeal metastases from non-small cell lung cancer.

Journal: Cell discovery
Published: March 27, 2025

Unraveling the genetic interplay between sleep disorders and Alzheimer's disease: From shared genes to potential therapeutic targets.

Unraveling the genetic interplay between sleep disorders and Alzheimer's disease: From shared genes to potential therapeutic targets.

Journal: Journal of affective disorders
Published: March 18, 2025

Corrigendum to "Adiponectin attenuates neuronal apoptosis induced by hypoxia-ischemia via the activation of AdipoR1/APPL1/LKB1/AMPK pathway in neonatal rats" [Neuropharmacology 133 (2018) 415-428/NP_7092].

Corrigendum to "Adiponectin attenuates neuronal apoptosis induced by hypoxia-ischemia via the activation of AdipoR1/APPL1/LKB1/AMPK pathway in neonatal rats" [Neuropharmacology 133 (2018) 415-428/NP_7092].

Journal: Neuropharmacology
Published: July 03, 2024

ALKBH5 facilitates tumor progression via an m6A-YTHDC1-dependent mechanism in glioma.

ALKBH5 facilitates tumor progression via an m6A-YTHDC1-dependent mechanism in glioma.

Journal: Cancer letters
Published: June 07, 2024

Framework nucleic acid-based nanoparticles enhance temozolomide sensitivity in glioblastoma.

Framework nucleic acid-based nanoparticles enhance temozolomide sensitivity in glioblastoma.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: May 31, 2024

IL-18, a therapeutic target for immunotherapy boosting, promotes temozolomide chemoresistance via the PI3K/AKT pathway in glioma.

IL-18, a therapeutic target for immunotherapy boosting, promotes temozolomide chemoresistance via the PI3K/AKT pathway in glioma.

Journal: Journal of translational medicine
Published: April 04, 2024

The effect of aperiodic components in distinguishing Alzheimer's disease from frontotemporal dementia.

The effect of aperiodic components in distinguishing Alzheimer's disease from frontotemporal dementia.

Journal: GeroScience
Published: June 23, 2023
Showing 1-12 of 18

Last Updated: 09/26/2026